Iambic upgrades AI model Enchant v3 for drug discovery
Life sciences company Iambic has unveiled Enchant v3, the next generation of its AI-driven multimodal transformer model designed to advance end-to-end drug discovery and development. The model features 41 billion parameters and has been trained on over 6,000 molecular properties across 16 biomedical data modalities.